Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jan;74(1):14-8.
doi: 10.1136/bjo.74.1.14.

Histopathological findings in the iris of dapsone treated leprosy patients

Affiliations

Histopathological findings in the iris of dapsone treated leprosy patients

F Brandt et al. Br J Ophthalmol. 1990 Jan.

Abstract

From 43 Nepalese leprosy patients skin smear negative, and treated with dapsone (diamino diphenyl sulphone), and without any sign of active leprosy or iritis, specimens from iridectomy during cataract surgery were studied histopathologically. Of 49 iris specimens only six (12%) were found to be without any histopathological change. Atrophy of the iris stroma was seen in 63% and neovascularisation in 6% of all cases. In 16% in which the dilator muscle could be detected, it was atrophic, and in 11% the pigmented epithelium was thinned and atrophic. Cellular inflammatory infiltrations were seen in 88% of all specimens. They were mostly slight in eyes which before operation had been without posterior synechiae of the iris. In most of the eyes in which posterior synechiae had been present moderate or heavy inflammatory cell infiltrates composed of lymphocytes and plasma cells, often associated with macrophages, neutrophils, or eosinophils, were found. In five iris specimens acid fast bacilli were present. This raises the question whether these can survive systemically despite dapsone chemotherapy in the iris, thus leading to dapsone-resistant leprosy and to recurrent iritis.

PubMed Disclaimer

References

    1. Int J Lepr Other Mycobact Dis. 1988 Jun;56(2):238-42 - PubMed
    1. Lepr Rev. 1988 Dec;59(4):341-6 - PubMed
    1. Br J Ophthalmol. 1981 Apr;65(4):231-9 - PubMed
    1. Klin Monbl Augenheilkd. 1984 Jan;184(1):28-31 - PubMed
    1. Fortschr Ophthalmol. 1983;79(5):455-7 - PubMed

Publication types

MeSH terms